← Medication Database
Oncology

Ninlaro

Generic: ixazomib

Manufacturer: Takeda  ·  Program: Takeda Oncology Here2Assist

Apply for Assistance

Eligibility Criteria

Insurance Requirement

Uninsured, underinsured, or commercially insured patients; Medicare Part D patients may be eligible if they meet specific financial criteria and have been denied a Low Income Subsidy (LIS).

Residency

U.S. resident or resident of U.S. territories

Income Threshold

Up to 500% FPL

Individual Income Limit

$75,300/year

Calculated based on 500% of the 2025 Federal Poverty Level.

Program Information

Processing Time

24-48 hours

Delivery Method

shipped to patient

Application Method

Multiple

Reauthorization

Required — annual

Typically Required Documents

ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.

  • Completed application form with physician and patient signatures
  • Proof of income (e.g., most recent Tax Return, W-2, or pay stubs)
  • Copy of insurance cards (if applicable)

Indicated For

Multiple myeloma

About This Medication

# Takeda Oncology Here2Assist Program Guide: Getting Help Paying for Ninlaro (ixazomib) --- ## Who Qualifies for the Takeda Oncology Here2Assist? If you have been prescribed Ninlaro (ixazomib) for multiple myeloma, you may be able to get your medication at little or no cost through the **Takeda Oncology Here2Assist** program. To qualify, a single-person household must earn no more than **$75,300 per year**. Larger households have higher income limits, which are covered in detail below. The program is open to patients who are uninsured, underinsured, or covered by commercial (private) insurance. Medicare Part D patients may also be eligible under specific financial conditions. You do not have to be completely without insurance to apply — many patients who have coverage but still face high out-of-pocket costs qualify for meaningful financial relief through this program. --- ## About Ninlaro (ixazomib) Ninlaro (ixazomib) is a prescription oral capsule used to treat multiple myeloma, a cancer of the plasma cells found in bone marrow. It belongs to a class of medications called proteasome inhibitors and is approved by the U.S. Food and Drug Administration (FDA) for use in combination with other medications in patients who have received at least one prior therapy. Because Ninlaro is a specialty oncology medication, it carries a high list price that can reach tens of thousands of dollars per month without insurance or assistance. Even patients with insurance may face substantial copays, coinsurance, or deductible costs. The Here2Assist program exists specifically to help reduce or eliminate those financial barriers for eligible patients. --- ## Income Eligibility: Full Breakdown Eligibility for Here2Assist is based on your household's total annual income. The program uses thresholds set at 500% of the 2025 Federal Poverty Level. The limits by household size are: | Household Size | Max Annual Income | |---|---| | 1 person | $75,300 | | 2 persons | $102,200 | | 3 persons | $129,100 | | 4 persons | $156,000 | If your household has more than four people, the income limit increases further — contact Here2Assist directly at **(844) 817-6468** to confirm the threshold for your household size. Income is typically verified using your most recent federal tax return, your most recent W-2 form, or three months of recent pay stubs. If your income has changed significantly from the prior year — for example, due to job loss or retirement — you may be able to document current income using recent pay stubs or other supporting records. If your income is above the stated limit for your household size, you may not qualify for free medication through this program, but you should still explore the savings card option described in the Alternatives section below. --- ## Insurance Requirements Explained - **If you are uninsured:** You may qualify to receive Ninlaro at no cost through the free drug program. You will not need to submit insurance cards, but you will still need to complete the application and provide proof of income. - **If you have Medicare Part D:** You may be eligible for assistance, but only if you meet specific financial criteria and have already been denied a Low Income Subsidy (LIS), also called Extra Help. Medicare patients who have not yet applied for LIS should do so first, as that program may provide separate cost-sharing relief. - **If you have private insurance that covers less than 50% of your costs (underinsured):** You may qualify for the free drug program. Patients in this situation should document their out-of-pocket cost share when applying. - **If you have Medicaid:** Medicaid patients are generally not eligible for manufacturer patient assistance programs because federal rules typically prohibit manufacturers from providing free drugs to Medicaid beneficiaries. Contact Here2Assist to discuss your specific situation. --- ## Step-by-Step: How to Apply 1. **Gather your documents before you start.** You will need: a completed application form with both your signature and your physician's signature, proof of income (most recent tax return, W-2, or three months of pay stubs), and a copy of your insurance card or cards if you have coverage. 2. **Choose your application method.** - **Online:** Visit **https://www.here2assist.com/** to complete and submit the application electronically. This is typically the fastest method. - **By phone:** Call **(844) 817-6468** to speak with a program representative who can walk you through the process. - **By fax:** Fax your completed paper application and supporting documents to **(844) 449-8697**. 3. **Have your prescriber involved early.** The application requires your physician's signature, so coordinate with your oncology team before submitting. Many oncology offices are familiar with Here2Assist and can help complete their portion. 4. **Submit all documents at the same time.** Incomplete applications take longer to process. Make sure every required document is included with your submission. 5. **Wait for a decision.** Once a complete application is received, a determination is typically made within **24 to 48 hours**. 6. **Confirm your approval and prescription details** with your care team or the Here2Assist representative who contacts you after the decision is made. --- ## What to Expect: Timeline and Delivery After you submit a complete application, Here2Assist typically processes it within **24 to 48 hours**. If approved, you will be notified by the program. Ninlaro is shipped directly to your home, so you do not need to pick it up at a pharmacy or your doctor's office. You should make sure someone is available to receive the shipment, as specialty medications often require a signature upon delivery. Because approval is not permanent, you will need to **reauthorize your enrollment once per year**. Watch for renewal notices from Here2Assist as your annual anniversary approaches, and plan to resubmit updated income documentation at that time to avoid a gap in your medication supply. --- ## Alternatives If You Don't Qualify **Biosimilars:** There are currently no FDA-approved biosimilar alternatives to Ninlaro (ixazomib). This means lower-cost substitution options are not available at this time. **Manufacturer savings card:** If you have commercial (private) insurance and do not qualify for the free drug program, Takeda offers a copay savings card for Ninlaro. This card can help reduce your out-of-pocket costs at the pharmacy. You can enroll at **https://www.here2assist.com/patient/ninlaro/copay**. **State Pharmaceutical Assistance Programs (SPAPs):** Many states operate their own programs to help residents afford prescription medications. Eligibility and benefits vary by state. Your social worker, oncology navigator, or state health department website can help you find programs available where you live. **NeedyMeds.org:** This free, nonprofit database lists hundreds of patient assistance programs, copay assistance options, and disease-specific resources. You can search by drug name or diagnosis at no cost at **www.needymeds.org**. --- > *This guide is for informational purposes only and does not constitute medical or legal advice. Eligibility determinations are made solely by Takeda. Program terms may change — verify current requirements at [https://www.ninlaro.com/patient-support](https://www.ninlaro.com/patient-support) before applying.* ---

Program information last verified: February 27, 2026

Ready to apply for Ninlaro assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications